Radionuclide Therapy Improvement Using Radiosensitizers: Preclinical Studies & Future Outlook
Time: 1:30 pm
day: Day 2 - P&T Track PM
Details:
- Showcasing various preclinical studies (in vitro and in vivo)
- Addressing different combination treatments of 177Lu-based radionuclide therapies and agents such as DNA damage repair inhibitors
